title: Levodopa in the treatment of Parkinson's disease: a consensus meeting.
authors.affiliation: INSERM U 289 & Fédération de Neurologie, Hôpital de la Salpêtrière-47, Paris, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Agid
authors.forename: E
authors.initials: E
authors.lastname: Ahlskog
authors.forename: A
authors.initials: A
authors.lastname: Albanese
authors.forename: D
authors.initials: D
authors.lastname: Calne
authors.forename: T
authors.initials: T
authors.lastname: Chase
authors.forename: J
authors.initials: J
authors.lastname: De Yebenes
authors.forename: S
authors.initials: S
authors.lastname: Factor
authors.forename: S
authors.initials: S
authors.lastname: Fahn
authors.forename: O
authors.initials: O
authors.lastname: Gershanik
authors.forename: C
authors.initials: C
authors.lastname: Goetz
authors.forename: W
authors.initials: W
authors.lastname: Koller
authors.forename: M
authors.initials: M
authors.lastname: Kurth
authors.forename: A
authors.initials: A
authors.lastname: Lang
authors.forename: A
authors.initials: A
authors.lastname: Lees
authors.forename: P
authors.initials: P
authors.lastname: Lewitt
authors.forename: D
authors.initials: D
authors.lastname: Marsden
authors.forename: E
authors.initials: E
authors.lastname: Melamed
authors.forename: P P
authors.initials: PP
authors.lastname: Michel
authors.forename: Y
authors.initials: Y
authors.lastname: Mizuno
authors.forename: J
authors.initials: J
authors.lastname: Obeso
authors.forename: W
authors.initials: W
authors.lastname: Oertel
authors.forename: W
authors.initials: W
authors.lastname: Olanow
authors.forename: W
authors.initials: W
authors.lastname: Poewe
authors.forename: P
authors.initials: P
authors.lastname: Pollak
authors.forename: E
authors.initials: E
authors.lastname: Tolosa
mesh_terms: D000818:Animals; D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001921:Brain / Q000187:drug effects; D016923:Cell Death / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa